GDP

GDP regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GDP, covering 2022-07-01 to 2022-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL [Phase 1, Phase 2]